Skip to main content

TYVASO DPI IS NOW APPROVED

WHAT IS TYVASO?

TYVASO is an inhaled prostacyclin mimetic that is delivered directly to the lungs1,2

Direct-to-lung delivery

  • Delivers to the site of disease with less off-target exposure3

  • Allows for fast titration to reach target dose2,4

  • Convenience and flexibility that fits into patients’ daily routine2

Review the mechanism of action (MOA) of TYVASO to consider how inhaled prostacyclin delivery may benefit your patients.

LEARN MORE

TYVASO DPI

The proven efficacy of TYVASO in the palm of your hand1,5

  • Simple to use

  • Small and portable

  • Demonstrated safety profile1

  • High patient satisfaction5*

In a clinical study, 96% (44/46) of patients reported satisfaction with TYVASO DPI at week 3 compared with 31% (16/51) of patients satisfied with the TYVASO nebulizer at baseline.5

Discover how TYVASO DPI can provide your patients with a simple-to-use option for the treatment of PAH.1

DPI hand slide

TYVASO NEBULIZER

Dosing at home or on the go

  • Convenient once-daily setup

  • Each treatment session only takes approximately 2-3 minutes2†

  • Cordless flexibility

†Compared with other nebulizer systems.

View a video about the TYVASO nebulizer: how to prepare and use the device and how inhaled prostacyclin is delivered directly to the lungs.

Tyvaso inhaled prostacyclin device